Amal Ltd 2017-18

89 Note 30 Expenditure on Corporate Social Responsibility initiatives Gross amount required to be spent by the Company during the year is ` 6.46 lakhs (March 31, 2017: Nil) Note 31 Capital Management a) The Company was declared sick by the BIFR through its order dated July 31, 2006. Presently, the Modified Sanctioned Scheme (MS-13) approved by BIFR in its meeting held on July 01, 2013 continues to be in place. The management is taking all steps to maximise Shareholder value as per approved MS-13 to revive the Company and make its net worth positive. b) The Company has not declared any dividend. Note 32: Fair value measurements a) Financial instruments by category ( ` 000) Particulars As at March 31, 2018 As at March 31, 2017 FVPL FVOCI Amortised cost FVPL FVOCI Amortised cost Financial assets Investments Equity instruments 210 210 Mutual funds 41,874 - - 19,082 - - Trade receivables - - 83,938 - - 42,933 Security deposits for utilities and premises - - 3,905 - - 3,905 Cash and cash equivalents - - 31,730 - - 17,490 Bank balances other than cash and cash equivalents - - - - - 500 Total financial assets 42,084 - 1,19,573 19,292 - 64,828 Financial liabilities Borrowings - - 1,34,406 - - 1,49,667 Trade payables - - 16,330 - - 16,608 Employee benefits payable - - 699 - - 707 Payable towards expenses - - 3,111 - - 4,042 Retentions payable - - 670 - - 454 Total financial liabilities - - 1,55,216 - - 1,71,478 b) Fair value hierarchy This section explains the judgements and estimates made in determining the fair values of the financial instruments that are (a) recognised and measured at fair value and (b) measured at amortised cost and for which fair values are disclosed in the Financial Statements. To provide an indication about the reliability of the inputs used in determining fair value, the Company has classified its financial instruments into the 3 levels prescribed under the Accounting Standard. An explanation of each level follows underneath the table. Notes to the Financial Statements

RkJQdWJsaXNoZXIy MjA2MDI2